Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Financial Reports

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

April 29, Appendix 4C and Quarterly Update

Financial Reports 2022, News & Announcements 2022By PharmAust29/04/2022

220409_A4C_quarterly update

Read more

February 18, Appendix 4D and Half Year Update

Financial Reports 2022, News & Announcements 2022By PharmAust18/02/2022

220218_Appendix4D and Half Year Update

Read more

August 18, Appendix 4G

Financial Reports 2021, News and Announcements 2021By PharmAust18/08/2021

210818_Appendix 4G

Read more

August 18, Appendix 4E

Financial Reports 2021, News and Announcements 2021By PharmAust18/08/2021

210818_Appendix 4E

Read more

July 28, Appendix 4C and Quarterly Update

Financial Reports 2021, News and Announcements 2021By PharmAust28/07/2021

210728_Appendix 4C and Q Update

Read more

April 29, Appendix 4C and Quarterly Update

Financial Reports 2021, News and Announcements 2021By PharmAust29/04/2021

210429_Appendix 4C and Quarterly Update

Read more

February 26, Appendix 4D & Half Year Report

Financial Reports 2021, News and Announcements 2021By PharmAust26/02/2021

210226_Appendix 4D, half yearly report

Read more

30 April, Appendix 3G Notification of Issue, Conversion or Payment of Equity + Securities

Financial Reports 2020, News & Announcements 2020By PharmAust30/04/2020

200430_Performance rights

Read more

20 April, Appendix 4C and Quarterly Update

Financial Reports 2020, News & Announcements 2020By PharmAust20/04/2020

200420_Appendix 4C and Quarterly Update

Read more

31 March, Expiry of Options

Financial Reports 2020, News & Announcements 2020By PharmAust31/03/2020

200313_Expiry of Options

Read more

28 Feb, Appendix 4D & Half Year Report

Financial Reports 2020, News & Announcements 2020By PharmAust28/02/2020

200228_Appendix 4D & Half Year Report

Read more

28 January, Appendix 4C and Quarterly Update

Financial Reports 2020, News & Announcements 2020By PharmAust28/01/2020

200128_Appendix 4C and Quarterly Update

Read more

Appendix 3B, Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust19/11/2019

191121_Exercise of Options

Read more

Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust08/11/2019

191108_Appendix 3B – Exercise of Options

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAust01/11/2019

191101_Appendix 4C and Quarterly Update

Read more

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAust10/10/2019

191010_Appendix 3B & s708 Notice

Read more

26 September, Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust26/09/2019

190926_Exercise of Options

Read more

19 September: Appendix 4G & Corporate Governance Statement

Financial Reports 2019, News & Announcements 2019By PharmAust23/09/2019

190919_Appendix 4G & Corporate Governance Statement

Read more

19 September: Annual_Report

Financial Reports 2019, News & Announcements 2019By PharmAust19/09/2019

190919_Annual_Report

Read more

17 September: Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAust17/09/2019

190917_Appendix 3B Exercise of Options

Read more

Appendix 4E Preliminary Final Report

Financial Reports 2019, News & Announcements 2019By PharmAust30/08/2019

190830_Preliminary Final Report

Read more

Appendix 3B and s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAust28/08/2019

190828_Appendix 3B & s708 notice

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAust30/07/2019

4471277nx3858c

Read more

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAust26/07/2019

190729_Unlisted Options Issuance

Read more

23 July 2019, Change in Substantial Holding

Financial Reports 2019, News & Announcements 2019By PharmAust23/07/2019

Change in Substantial Holding

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAust01/05/2019

444r10lc14lvz2

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust24/04/2019

Appendix 3B

Read more

Appendix 4D and Financial Report

Financial Reports 2019, News & Announcements 2019By PharmAust01/03/2019

190301_Appendix-4D-and-Financial-Report

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By PharmAust18/02/2019

190218_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust18/02/2019

190218_Appendix 3B

Read more

Appendix 3B Amendment

Financial Reports 2019, News & Announcements 2019By PharmAust14/02/2019

190214_Appendix 3B Amendment

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By PharmAust07/02/2019

190207_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By PharmAust07/02/2019

190207_Appendix 3B

Read more

December 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2019, News & Announcements 2019By PharmAust31/01/2019

190131_4C

Read more

Top 20 Shareholders December 2022

01/01/2023

Top 20 Shareholders November 2022

01/12/2022

September 2018 Appendix 4C Quarterly Report and Company Update

01/11/2018

PharmAust 2018 Annual Report

01/10/2018

Preliminary Final Statements to the ASX

03/09/2018

Top 20 Shareholders August 2018

17/08/2018

Top 20 Shareholders July 2018

13/07/2018

Top 20 Shareholders June 2018

10/06/2018

PharmAust Appendix 4C and Shareholders Update (Q3, 2018 FY)

01/05/2018

Top 20 Shareholders April 2018

27/04/2018

SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

20/03/2018

Appendix 3B: New issue announcement, application for quotation of additional securities and agreement

16/03/2018

Appendix 3Y: Change of Director’s Interest Notice

16/03/2018

Appendix 4D – Half Yearly Report for Dec, 2017

01/03/2018

Top 20 Shareholders Feb 2018

26/02/2018

Results of General Meeting

26/02/2018

Appendix 4C and Shareholders Update (Q2, 2018 FY)

31/01/2018

NOTICE OF GENERAL MEETING AND EXPLANATORY STATEMENT

29/01/2018

December 1, Demonstration Batch Small MPL Tablets Completed

01/12/2021

November 15, New Zealand Joins Phase 2B Pet Dog Trial

15/11/2021

Top 20 Shareholders December 2017

15/12/2017

Results of AGM 2017

01/12/2017

Trading Halt Request

01/12/2017

AGM Presentation 2017

01/12/2017

AGM notice

01/11/2017

Appendix 4C – Quarterly Report and Company Update for the period ended 30 September 2017

30/09/2017

Appendix 4G

31/08/2017

Appendix 4E & Annual Report

10/07/2017

Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017

30/06/2017

Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017

13/04/2017

Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016

31/01/2017

Appendix 4D Half-Year Report for the period ended 31 December 2016

31/12/2016

Appendix 4D Half-Year Report for the period ended 31 December 2016

31/12/2016

Appendix 4D & Half Yearly Report and Accounts

31/12/2016

Results of annual general meetings

11/11/2016

Appendix 3B

11/11/2016

Notice of annual general meeting and explanatory statement

11/11/2016

Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016

31/10/2016

Appendix 4E Annual Report & Full Year Statutory Accounts 2016

01/07/2016

Appendix 4G & Corporate Governance Statement

30/06/2016

Appendix 4C Quarterly Report & Brief Company Update

29/04/2016

Appendix 4C – Quarterly Report & Company Update

29/01/2016

Appendix 3B

05/11/2015

Appendix 4C Quarterly Report & Company Update

30/10/2015

Results of Annual General Meetings 2015

27/10/2015

PharmAust Annual Report 2015

28/08/2015

Appendix 4G & Corporate Governance Statement

30/06/2015

Appendix 4E & Full Year Statutory Accounts

30/06/2015

Appendix 4C – Quarterly Report & Company Update

30/06/2015

Results of Meeting

26/05/2015

Notice of General Meeting_Proxy Form

26/05/2015

Appendix 4C Quarterly Report & Company Update

31/03/2015

Clarification to Quarterly Report & Company Update

03/02/2015

Appendix 4C – Quarterly Report & Company Update

30/01/2015

Shareholder Update – Human & Canine Trials

25/01/2015

Appendix 4D and Half Yearly Report & Accounts

31/12/2014
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
4 Sep

Great spread on Louie the Beagle in @AustVetMag Australian Veterinarian Magazine - Spring Issue

https://simplebooklet.com/theaustralianveterinarianmagazine_spring_2023_issue21

Reply on Twitter 1698509346102010223 Retweet on Twitter 1698509346102010223 2 Like on Twitter 1698509346102010223 9 Twitter 1698509346102010223
pharmaust PharmAust @pharmaust ·
2 Sep

PharmAust CEO Dr Michael Thurn spoke with @Biotech_Buzz from @StocksDownUnder and @PSR_Insights about the clinical success with our flagship drug, Monepantel (MPL)

🎥 https://youtu.be/oCfvzseRDxQ?si=iBZu_GMBIg5oSiMX

Reply on Twitter 1697769500807176530 Retweet on Twitter 1697769500807176530 2 Like on Twitter 1697769500807176530 13 Twitter 1697769500807176530
pharmaust PharmAust @pharmaust ·
29 Aug

New CEO to take the helm as PharmAust progresses clinical studies

Reply on Twitter 1696342181496443106 Retweet on Twitter 1696342181496443106 2 Like on Twitter 1696342181496443106 7 Twitter 1696342181496443106
Load More

Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top